Diffusion Pharmaceuticals Inc DFFN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:40 PM EST
1.19quote price arrow up+0.07 (+6.25%)
Volume
5,217,425
52 week range
0.25 - 1.85

...

Loading . . .

KEY STATS

  • Open1.17
  • Day High1.23
  • Day Low1.13
  • Prev Close1.12
  • 52 Week High1.85
  • 52 Week High Date02/17/21
  • 52 Week Low0.25
  • 52 Week Low Date03/19/20
  • Market Cap121.00M
  • Shares Out101.68M
  • 10 Day Average Volume27.46M
  • Dividend-
  • Dividend Yield-
  • Beta1.71
  • 1 Year % Change187.8

RATIOS/PROFITABILITY

  • EPS (TTM)-0.49
  • P/E (TTM)-2.41
  • Fwd P/E (NTM)-5.17
  • EBITDA (MRQ)-14.742M
  • ROE (MRQ)-74.93%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/18/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Diffusion Pharmaceuticals Inc News

There is no recent news for this security.

Latest DFFN News From Our Partners

QUOTE FINDER

Profile

MORE
Diffusion Pharmaceuticals Inc. is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy. The Company's lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC) is used in various cancer types, in which tumor oxygen deprivation (hypoxia) is known to diminish the effectiveness of treatments. The Company's Diffusion's technology is targeted at...
Address
2020 Avon Ct Ste 4
Charlottesville, VA
22902-8734
United States